XML 43 R31.htm IDEA: XBRL DOCUMENT v3.24.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Assets and Liabilities Measured at Fair Value on Recurring Basis
The following tables present the fair value of assets and liabilities measured at fair value on a recurring basis as of June 30, 2024 and December 31, 2023 (dollars in millions):
As of June 30, 2024
Fair Value Measured and Recorded Using
Level 1Level 2Level 3Total
Assets
Available for sale debt securities:
U.S. treasury securities$10 $— $— $10 
Corporate debt securities— 16 — 16 
Total available for sale debt securities10 16 — 26 
Equity securities65 — — 65 
Investments in unconsolidated subsidiaries96 — 457 553 
Warehouse receivables— 973 — 973 
Other assets— 12 31 43 
Total assets at fair value$171 $1,001 $488 $1,660 
Liabilities
Contingent consideration— — 40 40 
Total liabilities at fair value$— $— $40 $40 
As of December 31, 2023
Fair Value Measured and Recorded Using
Level 1Level 2Level 3Total
Assets
Available for sale debt securities:
U.S. treasury securities$12 $— $— $12 
Debt securities issued by U.S. federal agencies— 11 — 11 
Corporate debt securities— 44 — 44 
Asset-backed securities— — 
Total available for sale debt securities12 56 — 68 
Equity securities41 — — 41 
Investments in unconsolidated subsidiaries168 — 477 645 
Warehouse receivables— 675 — 675 
Other assets— — 16 16 
Total assets at fair value$221 $731 $493 $1,445 
Liabilities
Contingent consideration— — 36 36 
Other liabilities— — 
Total liabilities at fair value$— $$36 $41 
Schedule of Reconciliation for Assets Measured at Fair Value
The tables below present a reconciliation for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (dollars in millions):
Investment in Unconsolidated SubsidiariesOther AssetsContingent Consideration
Balance as of March 31, 2024$458 $18 $43 
Transfer in (out)— — — 
Net change in fair value(1)10 (3)
Purchases / Additions— 
Sales / Payments— — (2)
Balance as of June 30, 2024$457 $31 $40 
Balance as of December 31, 2023$477 $16 $36 
Transfer in (out)— — — 
Net change in fair value(20)(3)
Purchases / Additions— 
Sales / Payments$— $— $(2)
Balance as of June 30, 2024$457 $31 $40 
Net change in fair value, included in the table above, is reported in Net income as follows:
Category of Assets/Liabilities using Unobservable Inputs
Consolidated Financial Statements
Investments in unconsolidated subsidiariesEquity (loss) income from unconsolidated subsidiaries
Other assets (liabilities)Other income
Contingent consideration (short term)
Accounts payable and accrued expenses
Contingent consideration (long term)
Other liabilities
Schedule of Reconciliation for Liabilities Measured at Fair Value
The tables below present a reconciliation for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (dollars in millions):
Investment in Unconsolidated SubsidiariesOther AssetsContingent Consideration
Balance as of March 31, 2024$458 $18 $43 
Transfer in (out)— — — 
Net change in fair value(1)10 (3)
Purchases / Additions— 
Sales / Payments— — (2)
Balance as of June 30, 2024$457 $31 $40 
Balance as of December 31, 2023$477 $16 $36 
Transfer in (out)— — — 
Net change in fair value(20)(3)
Purchases / Additions— 
Sales / Payments$— $— $(2)
Balance as of June 30, 2024$457 $31 $40 
Net change in fair value, included in the table above, is reported in Net income as follows:
Category of Assets/Liabilities using Unobservable Inputs
Consolidated Financial Statements
Investments in unconsolidated subsidiariesEquity (loss) income from unconsolidated subsidiaries
Other assets (liabilities)Other income
Contingent consideration (short term)
Accounts payable and accrued expenses
Contingent consideration (long term)
Other liabilities
Schedule of Fair Value Measurement Inputs and Valuation Techniques
The table below presents information about the significant unobservable inputs used for recurring fair value measurements for certain Level 3 instruments as of June 30, 2024:
Valuation TechniqueUnobservable InputRangeWeighted Average
Investment in unconsolidated subsidiariesDiscounted cash flowDiscount rate18 %— 
Monte CarloVolatility
35% - 61%
36 %
Discount rate25 %— 
Other assetsDiscounted cash flowDiscount rate18 %— 
Contingent considerationMonte CarloVolatility21 %— 
Discount rate
%— 
Discounted estimated payments
Discount rate
5% - 6%
%
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments
Estimated Fair Value
Carrying Value
Financial instrument
June 30, 2024December 31, 2023June 30, 2024December 31, 2023
Senior term loans
$736 $746 $741 $752 
5.950% senior notes
1,012 1,049 975 974 
4.875% senior notes
593 600 598 597 
5.500% senior notes
502 — 495 — 
2.500% senior notes
415 424 491 490